Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Artelo Biosciences Inc (NASDAQ: ARTL)

 
ARTL Technical Analysis
5
As on 20th Jun 2025 ARTL STOCK Price closed @ 5.77 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.34 & Strong Buy for SHORT-TERM with Stoploss of 1.47 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ARTLSTOCK Price

Open 6.07 Change Price %
High 6.11 1 Day -0.30 -4.94
Low 5.77 1 Week 4.64 410.62
Close 5.77 1 Month 4.74 460.19
Volume 6250 1 Year 4.42 327.41
52 Week High 7.20 | 52 Week Low 0.82
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
HCTI 0.03 0.00%
NVDA 143.85 -1.12%
GNLN 0.01 0.00%
PCSA 0.32 33.33%
INTC 21.08 -1.91%
LMDX 0.02 0.00%
LCID 2.19 -1.35%
NCNA 0.10 -16.67%
TSLA 322.16 0.03%
 
NASDAQ USA Top Gainers Stocks
ZWZZT 26.52 3688.57%
CBIO 15.00 2841.18%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
XXII 8.72 1881.82%
REDU 3.41 1075.86%
UNCY 6.34 846.27%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
NBSTU 2.00 -82.44%
TBIO 0.05 -80.00%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
 
 
ARTL
Daily Charts		 ARTL
Intraday Charts		 Whats New @
Bazaartrend		 ARTL
Free Analysis
 
ARTL Important Levels Intraday
RESISTANCE6.43
RESISTANCE6.22
RESISTANCE6.09
RESISTANCE5.96
SUPPORT5.58
SUPPORT5.45
SUPPORT5.32
SUPPORT5.11
 
ARTL Forecast June 2025
Share
4th UP Forecast6.6
3rd UP Forecast6.33
2nd UP Forecast6.17
1st UP Forecast6
1st DOWN Forecast5.54
2nd DOWN Forecast5.37
3rd DOWN Forecast5.21
4th DOWN Forecast4.94
 
ARTL Weekly Forecast
4th UP Forecast6.16
3rd UP Forecast6.03
2nd UP Forecast5.96
1st UP Forecast5.88
1st DOWN Forecast5.66
2nd DOWN Forecast5.58
3rd DOWN Forecast5.51
4th DOWN Forecast5.38
 
ARTL Forecast2025
4th UP Forecast18.35
3rd UP Forecast14.32
2nd UP Forecast11.82
1st UP Forecast9.33
1st DOWN Forecast2.21
2nd DOWN Forecast-0.28
3rd DOWN Forecast-2.78
4th DOWN Forecast-6.81
 
 
ARTL Other Details
Segment EQ
Market Capital 18108414.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ARTL Address
ARTL
 
ARTL Latest News
 
Your Comments and Response on Artelo Biosciences Inc
 
ARTL Business Profile
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1 clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences has research collaboration with Trinity College Dublin to Investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was founded in 2011 and is headquartered in La Jolla, California. Address: 888 Prospect Street, La Jolla, CA, United States, 92037
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service